Commercial Strategy Optimization

Infographic: The Clinical Practice Gaps in Precision Medicine

A snapshot of our analysis of the diagnostic challenges and patient journey changes over four years, providing insights to enhance precision medicine commercialization.

Addressing the Economic and
Operational Issues of the
Clinical Practice Gaps in NSCLC

This paper presents five key recommendations to tackle economic and operational barriers hindering access to precision medicine for NSCLC patients.

ASCO 2025 Highlights: Critical Advancements in Precision Oncology

Rethinking Drug Commercialization: Navigating a Shifting Biotech Investment Landscape

Explore strategies for biotech commercialization amid evolving investment landscapes, focusing on precision and rare disease therapies. Join industry experts in navigating funding challenges and enhancing patient outcomes.

Precision Medicine Execution: Accelerating Diagnostic Impact

Join our webinar to explore the 6A™ Strategic Framework for accelerating diagnostic impact in precision medicine through actionable insights and expert guidance.

Diagnostic Pathway Variation: Why Delivery Breaks Before Discovery

Discover how to improve access to diagnostic-driven therapies by addressing delivery challenges and enhancing engagement through real-world insights and targeted solutions.

Episode 9: The Hematopathology Team: from Slide to Strategy

In ep.9, listen to how Dr. Kuriakose and Dr. Gomez-Gelvez collaborate in hematopathology to enhance patient care and improve treatment strategies in this insightful podcast episode.

Identifying Barriers to Biomarker Testing Efficiency: 100 Laboratories Mapped in 3 Months

Diaceutics enhances biomarker testing efficiency, engaging over 150 labs to identify workflow barriers, optimize practices, and support timely clinical decision-making for better patient outcomes.

Driving Strategic Diagnostic Planning for a Targeted Therapy in Gender-specific Cancer

Drive awareness and adoption of precision therapy for gender-specific cancer through strategic diagnostic planning and tailored solutions from Diaceutics. Unlock your therapy's full potential.

D-Cubed Pharma ROI: The $20B Advantage

Discover how the D-Cubed Model transforms pharma ROI through diagnostics, data, and digital strategies, leading to faster drug launches and enhanced patient access.

Strategic Diagnostics in Action

Diaceutics accelerated gene therapy access by implementing a global strategy, reducing test result turnaround times from 28 days to 1 week and enhancing patient identification.

Strategies for Launch Success

Watch our Precision Medicine Webinar to explore strategies for successful therapy adoption and commercialization in the evolving precision medicine landscape.

Episode 1: HRD Testing from Clinic to Lab

Discover insights on HRD from leading experts in the latest episode of the Better Testing, Better Treatment podcast, designed for clinicians and laboratory professionals.

Navigating Precision Commercialization

Explore innovative strategies for precision commercialization in biopharma. Learn how to enhance launch models and accelerate market adoption of targeted therapies.

ESMO 2025: Top 5 Key Cancer Diagnostics Takeaways From Our Experts

Discover 5 key insights from ESMO 2025 on cancer diagnostics, focusing on ctDNA, antibody-drug conjugates, and innovative strategies for improving patient outcomes in precision medicine.

Episode 2: Artificial Intelligence in Breast Cancer: from Clinic to Lab 

Explore how AI is transforming breast cancer diagnosis with insights from experts Dr. Elie Rassy and Dr. Magali Lacroix-Triki in this enlightening podcast episode.

Precision Over Presence: Why Personalization At Scale Drives Better Patient Engagement

Discover how Diaceutics empowers pharma marketers with data-driven solutions for effective HCP targeting and improved commercial outcomes.

Advancing Precision Medicine Adoption in the Asia-Pacific (APAC) Region

Explore strategies and recommendations to enhance precision medicine adoption in the APAC region, improving patient access to testing and treatment solutions.

Unlocking Diagnostic Clarity to Accelerate Market-Ready Strategy 

Unlock diagnostic clarity to drive market readiness, enhance adoption, and mitigate launch risks with tailored strategies and insights from Diaceutics. Connect to realize your therapy's potential.

From Insight to Impact: Accelerating precision medicine adoption with the 6A™ Strategic Framework

Discover how the 6A™ Strategic Framework accelerates precision medicine adoption, revealing insights and strategies for successful commercialization and improved patient outcomes. Join our webinar for expert guidance.

The Operating Model Shaping Pharma’s Next Decade

Join industry leaders Peter Keeling and Rebecca Fryer as they discuss shaping the future of precision testing and commercialization in pharma during this insightful online event.

Delivering precision medicine success through a multi-year commercialization partnership

Discover how a global pharmaceutical leader successfully launched a first-in-class oncology therapy through strategic partnerships, accelerating testing readiness and driving adoption in precision medicine.

Driving Global Diagnostic Accuracy for Biomarker Quantification in a Female-Specific Cancer

Discover how Diaceutics enhanced biomarker quantification accuracy for a new cancer therapy, improving diagnosis and patient identification through global studies and targeted training for pathologists.

Precision Medicine Readiness Report 1

Read the first Precision Medicine Readiness Report, addressing diagnostic ecosystem challenges that hinder patient access and highlighting pharma's ongoing commercial readiness efforts.

Precision Medicine Readiness Report 2

In the second paper, discover how the Axis for Change manifesto aims to accelerate precision medicine testing from years to months, using NSCLC to highlight diagnostic flaws.

Precision Medicine Readiness Report 3

Explore the final report of the Axis for Change Manifesto, highlighting advancements in precision medicine and advocating for increased investment in diagnostic pathways for better patient access to treatments.

Why Commercial Strategy Must Step Up to Unlock Biomarker Testing and Actionability

Unlock the future of oncology with insights on biomarker testing, ADCs, ctDNA, and digital pathology trends shaping your commercial strategy. Stay competitive in precision medicine.

The Precision Medicine Webinar Series: Harnessing Real-World Data

Watch our second webinar in precision medicine series to explore data-driven strategies for therapy adoption, provider engagement, and improving patient outcomes in the evolving healthcare landscape.

The Precision Medicine Webinar Series: Cutting through the noise in clinical education

Watch our third Precision Medicine Webinar with Gosia Leitch to explore data-driven strategies that enhance physician engagement and boost biomarker testing rates for successful therapy adoption.

The Precision Medicine Webinar Series: Accelerate Precision Medicine

Watch the last webinar in our Precision Medicine Series from 12th December, 2024, to explore strategies for improving biomarker adoption and optimizing therapeutic outcomes in the evolving healthcare landscape.

Seamless Diagnostic Testing: 12 Recommendations to Drive Your Launch Strategy to Success

Explore key barriers to seamless diagnostic testing in precision medicine and discover strategies to enhance patient identification and treatment outcomes.

Embracing Precision Medicine: The Heart of Value-Based Care

Discover how Diaceutics advances value-based care through precision medicine, ensuring patients receive tailored treatments supported by robust data integration and innovative solutions.

Reigniting Momentum: A Curated Round‑Up of This Season’s Most Impactful Insights

Discover how real-time diagnostic insights and expert-led engagement can rebuild prescriber confidence and reignite brand momentum.

Building the Pathway for a First-In-Class Oncology Launch

Discover how Diaceutics built a successful commercialization pathway for a first-in-class oncology therapy, enabling timely patient identification and physician engagement in a rare biomarker population.

Join us at Fierce Pharma Week

Join us at Fierce Pharma Week to explore innovative diagnostic-driven therapy commercialization strategies. Engage with experts and discover how real-world data can enhance HCP engagement.

We're attending Fierce Pharma Week